GROUP ONE TRADING, L.P. - INFINITY PHARMACEUTICALS INC ownership

INFINITY PHARMACEUTICALS INC's ticker is and the CUSIP is 45665G953. A total of 3 filers reported holding INFINITY PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GROUP ONE TRADING, L.P. ownership history of INFINITY PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$1,165
-61.2%
2,1000.0%0.00%
Q3 2022$3,000
+200.0%
2,100
+50.0%
0.00%
Q2 2022$1,000
-50.0%
1,400
-6.7%
0.00%
Q1 2022$2,000
-88.2%
1,500
-80.5%
0.00%
Q4 2021$17,000
-94.1%
7,700
-90.9%
0.00%
Q3 2021$288,000
+69.4%
84,200
+48.2%
0.00%
Q2 2021$170,000
-1.2%
56,800
+6.4%
0.00%
Q1 2021$172,000
+975.0%
53,400
+602.6%
0.00%
Q4 2020$16,000
+166.7%
7,600
+117.1%
0.00%
Q2 2019$6,000
-14.3%
3,5000.0%0.00%
Q1 2019$7,000
-22.2%
3,500
-54.5%
0.00%
Q4 2018$9,000
-77.5%
7,700
-48.3%
0.00%
Q3 2018$40,000
+11.1%
14,900
-21.6%
0.00%
Q2 2018$36,000
+24.1%
19,000
+37.7%
0.00%
Q1 2018$29,000
-50.8%
13,800
-52.4%
0.00%
Q4 2017$59,000
-7.8%
29,000
-39.8%
0.00%
-100.0%
Q3 2017$64,000
+2033.3%
48,200
+2735.3%
0.00%
Q2 2017$3,000
-98.8%
1,700
-99.1%
0.00%
-100.0%
Q4 2016$247,000
+40.3%
182,800
+62.5%
0.00%0.0%
Q3 2016$176,000
-35.5%
112,500
+223.3%
0.00%
-33.3%
Q4 2015$273,000
-30.4%
34,800
-25.0%
0.00%
-40.0%
Q3 2015$392,000
-32.5%
46,400
-12.6%
0.01%
-37.5%
Q2 2015$581,000
-24.5%
53,100
-3.6%
0.01%
-33.3%
Q1 2015$770,000
-54.2%
55,100
-44.7%
0.01%
-52.0%
Q4 2014$1,682,000
-1.1%
99,600
-21.4%
0.02%
-3.8%
Q3 2014$1,700,000
+35.2%
126,700
+28.4%
0.03%
+36.8%
Q2 2014$1,257,000
-26.8%
98,700
-31.6%
0.02%
-34.5%
Q1 2014$1,717,000
-55.8%
144,400
-48.7%
0.03%
-50.8%
Q4 2013$3,888,000
+199.1%
281,500
+277.9%
0.06%
+136.0%
Q3 2013$1,300,000
+11.4%
74,500
+3.8%
0.02%
-13.8%
Q2 2013$1,167,00071,8000.03%
Other shareholders
INFINITY PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
GROUP ONE TRADING, L.P. 74,500$1,300,0000.02%
Citadel Advisors 23,600$412,0000.00%
View complete list of INFINITY PHARMACEUTICALS INC shareholders